Various Modes of Cell Death Induced by DNA Damage

Total Page:16

File Type:pdf, Size:1020Kb

Load more

Oncogene (2013) 32, 3789–3797 & 2013 Macmillan Publishers Limited All rights reserved 0950-9232/13 www.nature.com/onc REVIEW Various modes of cell death induced by DNA damage O Surova and B Zhivotovsky The consequences of DNA damage depend on the cell type and the severity of the damage. Mild DNA damage can be repaired with or without cell-cycle arrest. More severe and irreparable DNA injury leads to the appearance of cells that carry mutations or causes a shift towards induction of the senescence or cell death programs. Although for many years it was argued that DNA damage kills cells via apoptosis or necrosis, technical and methodological progress during the last few years has helped to reveal that this injury might also activate death by autophagy or mitotic catastrophe, which may then be followed by apoptosis or necrosis. The molecular basis underlying the decision-making process is currently the subject of intense investigation. Here, we review current knowledge about the response to DNA damage and subsequent signaling, with particular attention to cell death induction and the molecular switches between different cell death modalities following damage. Oncogene (2013) 32, 3789–3797; doi:10.1038/onc.2012.556; published online 3 December 2012 Keywords: DNA damage; cell death; p53; senescence; response INTRODUCTION cell-cycle arrest, whereas severe and irreparable injury shifts the Genomic integrity and stability is constantly threatened by DNA cellular response towards induction of the senescence or cell damage, which may arise from numerous environmental and death programs, such as apoptosis, mitotic catastrophe (MC), intrinsic sources. Failure to repair DNA damage can cause autophagy and necrosis. The molecular basis underlying the mutations, genomic instability, premature aging, mental multiplex decision-making process is currently the subject of intense retardation and other developmental disorders as well as cancer. investigation. Here, we review current knowledge about the Consequently, eukaryotes have evolved a complex set of DDR with particular attention to cell death induction and the mechanisms to sense different types of DNA damage and molecular switches between different cell death modalities safeguard the genome, the so-called DNA damage response following DNA damage. (DDR). The DDR comprises a multiple networks of signal transduction pathways initiated by sensing damage, followed by signal transmission to effectors through activation of a cascade of CELL SENESCENCE IN RESPONSE TO DNA DAMAGE phosphorylation events. A group of proteins, including mediator Cellular senescence is one of the consequences of severe or of DNA damage checkpoint protein 1 (Chk1; MDC1/NFBD1), 53BP1 irreparable DNA damage, especially DNA DSBs, and it is (p53-binding protein 1), the Mre11-Rad50-NBS1 (MRN) and the characterized by an irreversible growth arrest of cells in the G1 Rad9-Rad1-Hus1 (9-1-1) complexes, have been implicated as DNA phase. Cellular senescence limits the proliferation of DNA- damage sensors and recognize both double- and single-strand damaged cells that are at risk of neoplastic transformation. breaks (DSBs and SSBs, respectively) as well as regions of However, these cells remain metabolically active, showing a replication stress.1–4 Binding of the MRN and 9-1-1 complexes to greatly altered pattern of gene expression. The outcomes of the sites of DNA damage in chromatin activates the signal cellular senescence following DNA damage are highly dependent transducing kinase ataxia-telangiectasia mutated (ATM), the ATM on the cell type and physiological context. Cells of epithelial and and Rad3-related (ATR) kinase and the DNA-dependent protein stromal origin undergo senescence following severe DNA damage, kinase (DNA-PK). Once activated, ATR and ATM amplify the while lymphoid cells undergo apoptosis. In most cell types, damage signal by phosphorylating various substrates, including activation of p53 is crucial for initiating the senescence response key DDR proteins H2AX, BRCA1, NBS1, SMC1 (structural following DNA damage, and in certain cells p53 is also important maintenance of chromosome protein 1), MDC1 and 53BP1, as for maintaining the senescent growth arrest. p21waf1/cip1,asa well as repair proteins Ku70/80, Artemis and Rad-like proteins.5,6 crucial target of p53 and mediator of senescence, inhibits a Additionally, in order to allow time for DNA repair, ATM spectrum of cyclin-dependent kinases that regulate the phos- temporarily arrests the cell cycle by phosphorylation and phorylation of the retinoblastoma protein (pRb). The hypopho- activation of cell-cycle checkpoints. p53, as one of the main sphorylated form of pRb binds to the transcription factor E2F, targets of ATM/ATR, is a universal sensor of genotoxic stress and leading to transactivation of the genes essential for the G1-to-S has a key role in cellular responses to DNA damage, determining transition. On the other hand, p21 can mediate transient DNA the fate of cells towards either survival, which involves cell-cycle damage-induced growth arrest. It is still unclear what determines delay accompanied by repair of DNA damage, or cell death.7 whether cells senesce or arrest transiently. It is likely that rapid Depending on the cell type and the severity and extent of DNA DNA repair will quickly shut down p53–p21 signaling, whereas damage, the activated DDR can elicit different cellular responses incomplete or incorrect repair results in prolonged signaling and (Figure 1). Mild DNA damage normally leads to the induction of senescence.8–10 Division of Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Correspondence: Professor B Zhivotovsky, Institute of Environmental Medicine, Division of Toxicology, Karolinska Institutet, Nobels vag. 13, Box 210, Stockholm SE-171 77, Sweden. E-mail: [email protected] Received 27 August 2012; revised 2 October 2012; accepted 3 October 2012; published online 3 December 2012 DNA damage and cell death O Surova and B Zhivotovsky 3790 pathways are intact, have a preference toward senescence compared with transformed cells and that senescence is usually induced by lower levels of damage than those leading to apoptosis.13 Overall, p53 stands at the center of a complex DNA damage signal transduction pathway following DNA damage. MRN 9-1-1 Phosphorylation of p53 at Ser15, Thr18 and Ser376 and dephosphorylation at Ser392 has been detected in fibroblasts undergoing senescence.14 By contrast, phosphorylation at Ser46 sensing damage was shown to be associated with the induction of p53AIP1 (p53- G1 MDC1 BRCA1 regulated apoptosis-inducing protein 1) and apoptosis. A study on 53BP1 NBS1 MCF-7 cells demonstrated the role of different phosphorylation M S Chk1/Chk2 Ku70/80 ATM/ATR sites (Ser15 and Ser46), induction of p21 and high or low reactive oxygen species (ROS) levels in determining the dosage of G2 adriamycin that induced either apoptosis or senescence. Cells in cell cycle signal DNA repair checkpoints transductions these two states exhibited quite distinct time course profiles of the proteins p53, p21 and E2F1. As mentioned above, DNA damage can also activate Rb through the p16 pathway Cell Death to induce senescence. An in vivo study showed that, following TSC2/ PARP p53 cyclophosphamide treatment, a p53-dependent effect can also mTORC1 occur in an apoptosis-independent fashion by inducing cellular senescence in a p53- and p16-dependent manner.15 Thus, the genetic context, cell type or the specific activation of certain target genes upon DNA damage can favor either senescence or Necrosis Apoptosis Autophagy apoptosis. Figure 1. DNA damage response. DNA damage results from multiple environmental and intrinsic sources, activating a complex set of APOPTOSIS AS A FAST-ACTING RESPONSE TO DNA DAMAGE reactions called DNA damage response. This response is initiated by Like cellular senescence, apoptosis is activated in response to damage detection, followed by signal transmission to effectors and finally results in a number of cellular responses, such as induction of cellular stress and is executed when repair of DNA damage is slow cell-cycle arrest, repair of the lesions or, in case of non-repairable or incomplete. As mentioned above, it is still not fully understood damage, leads to activation of cell death program. A group of how cells decide whether to undergo senescence or apoptosis, proteins, including Mre11-Rad50-NBS1 (MRN complex) and the and despite the fact that most cells are capable of both, these Rad9-Rad1-Hus1 (9-1-1) complex, fulfilling a function of DNA processes seem to be mutually exclusive. Numerous studies have damage sensors, and recognized both DSBs and SSBs. Binding of clearly shown cross-talk between the processes of apoptosis and the MRN and 9-1-1 complexes to the sites of DNA damage in senescence, primarily at the level of p53, which is considered to be chromatin activates the signal transducing kinase ATM, preferen- a major player in the apoptotic response to genotoxins. The tially in response to DSBs and the disruption of chromatin structure. phosphorylation of p53 at Ser46 is the most prominent in priming By contrast, the ATR kinase is activating primarily in response to SSBs 16 and replication forks. The activation of DNA repair (orchestrated its apoptotic activity. Subsequently, homeodomain-interacting protein kinase 2 (HIPK2), a serine/threonine nuclear kinase, was by set of DNA damage response proteins, including BRCA1, NBS1, as 17,18 well as repair proteins Ku70/80
Recommended publications
  • Cellular Senescence Promotes Skin Carcinogenesis Through P38mapk and P44/P42mapk Signaling

    Cellular Senescence Promotes Skin Carcinogenesis Through P38mapk and P44/P42mapk Signaling

    Author Manuscript Published OnlineFirst on July 8, 2020; DOI: 10.1158/0008-5472.CAN-20-0108 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Cellular senescence promotes skin carcinogenesis through p38MAPK and p44/p42 MAPK signaling Fatouma Alimirah1, Tanya Pulido1, Alexis Valdovinos1, Sena Alptekin1,2, Emily Chang1, Elijah Jones1, Diego A. Diaz1, Jose Flores1, Michael C. Velarde1,3, Marco Demaria1,4, Albert R. Davalos1, Christopher D. Wiley1, Chandani Limbad1, Pierre-Yves Desprez1, and Judith Campisi1,5* 1Buck Institute for Research on Aging, Novato, CA 94945, USA 2Dokuz Eylul University School of Medicine, Izmir 35340, Turkey 3Institute of Biology, University of the Philippines Diliman, College of Science, Quezon City 1101, Philippines 4European Research Institute for the Biology of Ageing, University Medical Center Groningen, Groningen, the Netherlands 5Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA *Lead Contact: Judith Campisi, Buck Institute for Research on Aging, 8001 Redwood Boulevard, Novato, CA 94945, USA; Email: [email protected] or [email protected]. Telephone: 1-415-209-2066; Fax: 1-415-493-3640 Running title: Senescence and skin carcinogenesis Key words: doxorubicin, senescence-associated secretory phenotype, squamous cell carcinoma, microenvironment, inflammation, transgenic mice, tumorspheres Conflict of Interests JC is a co-founder of Unity Biotechnology and MD owns equity in Unity Biotechnology. All other authors declare no competing financial interests. Downloaded from cancerres.aacrjournals.org on September 25, 2021. © 2020 American Association for Cancer Research. Author Manuscript Published OnlineFirst on July 8, 2020; DOI: 10.1158/0008-5472.CAN-20-0108 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
  • Cellular Senescence: Friend Or Foe to Respiratory Viral Infections?

    Cellular Senescence: Friend Or Foe to Respiratory Viral Infections?

    Early View Perspective Cellular Senescence: Friend or Foe to Respiratory Viral Infections? William J. Kelley, Rachel L. Zemans, Daniel R. Goldstein Please cite this article as: Kelley WJ, Zemans RL, Goldstein DR. Cellular Senescence: Friend or Foe to Respiratory Viral Infections?. Eur Respir J 2020; in press (https://doi.org/10.1183/13993003.02708-2020). This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Copyright ©ERS 2020. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. Cellular Senescence: Friend or Foe to Respiratory Viral Infections? William J. Kelley1,2,3 , Rachel L. Zemans1,2 and Daniel R. Goldstein 1,2,3 1:Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA 2:Program in Immunology, University of Michigan, Ann Arbor, MI, USA 3:Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI USA Email of corresponding author: [email protected] Address of corresponding author: NCRC B020-209W 2800 Plymouth Road Ann Arbor, MI 48104, USA Word count: 2750 Take Home Senescence associates with fibrotic lung diseases. Emerging therapies to reduce senescence may treat chronic lung diseases, but the impact of senescence during acute respiratory viral infections is unclear and requires future investigation. Abstract Cellular senescence permanently arrests the replication of various cell types and contributes to age- associated diseases.
  • Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases

    Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases

    cells Review Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases Ping Song * , Junqing An and Ming-Hui Zou Center for Molecular and Translational Medicine, Georgia State University, 157 Decatur Street SE, Atlanta, GA 30303, USA; [email protected] (J.A.); [email protected] (M.-H.Z.) * Correspondence: [email protected]; Tel.: +1-404-413-6636 Received: 29 January 2020; Accepted: 5 March 2020; Published: 10 March 2020 Abstract: Senescent cells are generally characterized by permanent cell cycle arrest, metabolic alteration and activation, and apoptotic resistance in multiple organs due to various stressors. Excessive accumulation of senescent cells in numerous tissues leads to multiple chronic diseases, tissue dysfunction, age-related diseases and organ ageing. Immune cells can remove senescent cells. Immunaging or impaired innate and adaptive immune responses by senescent cells result in persistent accumulation of various senescent cells. Although senolytics—drugs that selectively remove senescent cells by inducing their apoptosis—are recent hot topics and are making significant research progress, senescence immunotherapies using immune cell-mediated clearance of senescent cells are emerging and promising strategies to fight ageing and multiple chronic diseases. This short review provides an overview of the research progress to date concerning senescent cell-caused chronic diseases and tissue ageing, as well as the regulation of senescence by small-molecule drugs in clinical trials and different roles and regulation of immune cells in the elimination of senescent cells. Mounting evidence indicates that immunotherapy targeting senescent cells combats ageing and chronic diseases and subsequently extends the healthy lifespan. Keywords: cellular senescence; senescence immunotherapy; ageing; chronic disease; ageing markers 1.
  • Cellular Senescence and Inflammaging in the Skin Microenvironment

    Cellular Senescence and Inflammaging in the Skin Microenvironment

    International Journal of Molecular Sciences Review Cellular Senescence and Inflammaging in the Skin Microenvironment Young In Lee 1,2 , Sooyeon Choi 1, Won Seok Roh 1 , Ju Hee Lee 1,2,* and Tae-Gyun Kim 1,* 1 Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul 107-11, Korea; [email protected] (Y.I.L.); [email protected] (S.C.); [email protected] (W.S.R.) 2 Scar Laser and Plastic Surgery Center, Yonsei Cancer Hospital, Yonsei University College of Medicine, Seoul 107-11, Korea * Correspondence: [email protected] (J.H.L.); [email protected] (T.-G.K.); Tel.: +82-2-2228-2080 (J.H.L. & T.-G.K.) Abstract: Cellular senescence and aging result in a reduced ability to manage persistent types of inflammation. Thus, the chronic low-level inflammation associated with aging phenotype is called “inflammaging”. Inflammaging is not only related with age-associated chronic systemic diseases such as cardiovascular disease and diabetes, but also skin aging. As the largest organ of the body, skin is continuously exposed to external stressors such as UV radiation, air particulate matter, and human microbiome. In this review article, we present mechanisms for accumulation of senescence cells in different compartments of the skin based on cell types, and their association with skin resident immune cells to describe changes in cutaneous immunity during the aging process. Keywords: inflammaging; senescence; skin; fibroblasts; keratinocytes; melanocytes; immune cells Citation: Lee, Y.I.; Choi, S.; Roh, W.S.; Lee, J.H.; Kim, T.-G. Cellular Senescence and Inflammaging in the 1.
  • Cellular Senescence and Apoptosis: How Cellular Responses Might Influence Aging Phenotypes

    Cellular Senescence and Apoptosis: How Cellular Responses Might Influence Aging Phenotypes

    Experimental Gerontology 38 (2003) 5–11 www.elsevier.com/locate/expgero Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes Judith Campisia,b,* aLife Sciences Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA 94720, USA bBuck Institute for Age Research, 8001 Redwood Blvd., Novato, CA 94945, USA Received 20 May 2002; accepted 28 May 2002 Abstract Aging in complex multi-cellular organisms such as mammals entails distinctive changes in cells and molecules that ultimately compromise the fitness of adult organisms. These cellular and molecular changes lead to the phenotypes we recognize as aging. This review discusses some of the cellular and molecular changes that occur with age, specifically changes that occur as a result of cellular responses that evolved to ameliorate the inevitable damage that is caused by endogenous and environmental insults. Because the force of natural selection declines with age, it is likely that these processes were never optimized during their evolution to benefit old organisms. That is, some age- related changes may be the result of gene activities that were selected for their beneficial effects in young organisms, but the same gene activities may have unselected, deleterious effects in old organisms, a phenomenon termed antagonistic pleiotropy. Two cellular processes, apoptosis and cellular senescence, may be examples of antagonistic pleiotropy. Both processes are essential for the viability and fitness of young organisms, but may contribute to aging phenotypes, including certain age-related diseases. q 2002 Elsevier Science Inc. All rights reserved. Keywords: Antagonistic pleiotropy; Apoptosis; Cancer; Cellular senescence; DNA damage response; Neurodegeneration; p53; Telomeres 1.
  • Werner and Hutchinson–Gilford Progeria Syndromes: Mechanistic Basis of Human Progeroid Diseases

    Werner and Hutchinson–Gilford Progeria Syndromes: Mechanistic Basis of Human Progeroid Diseases

    REVIEWS MECHANISMS OF DISEASE Werner and Hutchinson–Gilford progeria syndromes: mechanistic basis of human progeroid diseases Brian A. Kudlow*¶, Brian K. Kennedy* and Raymond J. Monnat Jr‡§ Abstract | Progeroid syndromes have been the focus of intense research in part because they might provide a window into the pathology of normal ageing. Werner syndrome and Hutchinson–Gilford progeria syndrome are two of the best characterized human progeroid diseases. Mutated genes that are associated with these syndromes have been identified, mouse models of disease have been developed, and molecular studies have implicated decreased cell proliferation and altered DNA-damage responses as common causal mechanisms in the pathogenesis of both diseases. Progeroid syndromes are heritable human disorders with therefore termed segmental, as opposed to global, features that suggest premature ageing1. These syndromes progeroid syndromes. Among the segmental progeroid have been well characterized as clinical disease entities, syndromes, the syndromes that most closely recapitu- and in many instances the associated genes and causative late the features of human ageing are Werner syndrome mutations have been identified. The identification of (WS), Hutchinson–Gilford progeria syndrome (HGPS), genes that are associated with premature-ageing-like Cockayne syndrome, ataxia-telangiectasia, and the con- syndromes has increased our understanding of molecu- stitutional chromosomal disorders of Down, Klinefelter lar pathways that protect cell viability and function, and
  • Cellular Senescence in the Kidney

    Cellular Senescence in the Kidney

    REVIEW www.jasn.org Cellular Senescence in the Kidney Marie-Helena Docherty,1 Eoin D. O’Sullivan,1,2 Joseph V. Bonventre,3 and David A. Ferenbach1,2 1Department of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK; 2Centre for Inflammation Research, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK; and 3Renal Division and Division of Engineering in Medicine, Brigham and Women’s Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts ABSTRACT Senescent cells have undergone permanent growth arrest, adopt an altered secre- to induce growth arrest and senescence in tory phenotype, and accumulate in the kidney and other organs with ageing and vitro, the key importance of telomere short- injury. Senescence has diverse physiologic roles and experimental studies support eninginhumanagingislesswellestab- its importance in nephrogenesis, successful tissue repair, and in opposing malignant lished, and is not the focus of this review.5 transformation. However, recent murine studies have shown that depletion of Although the association between aging chronically senescent cells extends healthy lifespan and delays age-associated and senescence is well recognized,6,7 only disease—implicating senescence and the senescence-associated secretory phenotype recently have experiments depleting senes- as drivers of organ dysfunction. Great interest is therefore focused on the manipu- cent cells in murine models been shown to lation of senescence as a novel therapeutic target in kidney disease. In this review, postpone the onset of age-related diseases we examine current knowledge and areas of ongoing uncertainty regarding senes- and extend healthy lifespan, reigniting clin- cence in the human kidney and experimental models. We summarize evidence sup- ical and research interest.8–10 porting the role of senescence in normal kidney development and homeostasis but also senescence-induced maladaptive repair, renal fibrosis, and transplant failure.
  • AP-1 Imprints a Reversible Transcriptional Program of Senescent Cells

    AP-1 Imprints a Reversible Transcriptional Program of Senescent Cells

    bioRxiv preprint doi: https://doi.org/10.1101/633594; this version posted May 9, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. AP-1 Imprints a Reversible Transcriptional Program of Senescent Cells Ricardo Iván Martínez-Zamudio1,5,8, Pierre-François Roux1,5, José Américo N L F de Freitas1,4, Lucas Robinson1,4, Gregory Doré1, Bin Sun6,7, Jesús Gil6,7, Utz Herbig8 and Oliver Bischof1,2,3,9* 1 Institut Pasteur, Laboratory of Nuclear Organization and Oncogenesis, Department of Cell Biology and Infection, 75015 Paris, France 2 INSERM, U993, 75015 Paris, France 3 Equipe Labellisée Fondation ARC pour la recherche sur le cancer, Paris, France 4 Université de Paris, Sorbonne Paris Cité, Paris, France 5 These authors contributed equally to this work 6 MRC London Institute of Medical Sciences (LMS), Du Cane Road, London, W12 0NN, UK. 7 Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK. 8 Department of Microbiology, Biochemistry & Molecular Genetics, Rutgers Biomedical & Health Sciences, Rutgers University, 205 South Orange Avenue, Newark, NJ 07103, USA 9 Lead contact *Correspondence: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/633594; this version posted May 9, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. SUMMARY Senescent cells play important physiological- and pathophysiological roles in tumor suppression, tissue regeneration, and aging.
  • Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy

    Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy

    cells Review Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy Francisco Triana-Martínez, María Isabel Loza and Eduardo Domínguez * Biofarma Research Group, Center for Research in molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela, Avenida de Barcelona s/n, 15782 Santiago de Compostela, Spain; [email protected] (F.T.-M.); [email protected] (M.I.L.) * Correspondence: [email protected]; Tel.: +34-88-1815-484 Received: 20 December 2019; Accepted: 29 January 2020; Published: 3 February 2020 Abstract: Here, we provide an overview of the importance of cellular fate in cancer as a group of diseases of abnormal cell growth. Tumor development and progression is a highly dynamic process, with several phases of evolution. The existing evidence about the origin and consequences of cancer cell fate specification (e.g., proliferation, senescence, stemness, dormancy, quiescence, and cell cycle re-entry) in the context of tumor formation and metastasis is discussed. The interplay between these dynamic tumor cell phenotypes, the microenvironment, and the immune system is also reviewed in relation to cancer. We focus on the role of senescence during cancer progression, with a special emphasis on its relationship with stemness and dormancy. Selective interventions on senescence and dormancy cell fates, including the specific targeting of cancer cell populations to prevent detrimental effects in aging and disease, are also reviewed. A new conceptual framework about the impact of synthetic lethal strategies by using senogenics and then senolytics is given, with the promise of future directions on innovative anticancer therapies. Keywords: cellular senescence; stemness; dormancy; quiescence; senolytic 1.
  • Cellular Senescence

    Cellular Senescence

    infoaging guides BIOLOGY OF AGING CELLULAR SENESCENCE An introduction to aging science brought to you by the American Federation for Aging Research WHAT IS CELLULAR no longer divide become what is that activate oncogenes—normal SENESCENCE? called “senescent.” Cells taken cellular genes that, when mutated, from older humans generally have contribute to the development Cellular senescence is a process shorter telomeres than cells from of cancer. These diverse triggers associated with aging that occurs young humans, so cells from older support the idea that cellular at the level of our cells. Cellular humans generally divide fewer senescence evolved primarily to senescence is sometimes called times before becoming replica- protect organisms from cancer. replicative senescence. Forty years tively senescent. ago, Dr. Leonard Hayflick and his Scientists have also noted that colleague, Dr. Paul Moorhead, Critically short telomeres, which senescent cells are different from discovered that many human resemble broken chromosomes, their younger counterparts. Like cells—particularly fibroblast cells, are not the only causes of ”senes- older people themselves, cells ap- which secrete substances that cence,” and so scientists often proaching senescence incur many provide structure to tissues—had use the more general term ”cellular biological losses or take on new a limited capacity to reproduce senescence.” Cellular senescence functions. Where younger cells themselves in culture by dividing. produce structural or functional They found that these and many proteins that maintain tissues in other normal human cells derived a healthy state, cells approaching from fetal, embryonic, or newborn senescence release enzymes that tissue can undergo between 40 break down these proteins. and 60 cell divisions, but then can divide no more.
  • Evidence of Oncogene-Induced Senescence in Thyroid Carcinogenesis

    Evidence of Oncogene-Induced Senescence in Thyroid Carcinogenesis

    Endocrine-Related Cancer (2011) 18 743–757 Evidence of oncogene-induced senescence in thyroid carcinogenesis Maria Grazia Vizioli, Patricia A Possik1, Eva Tarantino2, Katrin Meissl1, Maria Grazia Borrello, Claudia Miranda, Maria Chiara Anania, Sonia Pagliardini, Ettore Seregni3, Marco A Pierotti4, Silvana Pilotti2, Daniel S Peeper 1 and Angela Greco Molecular Mechanisms Unit, Department of Experimental Oncology and Molecular Medicine, IRCCS Foundation - Istituto Nazionale dei Tumori, Via G. Amadeo, 42 20133 Milan, Italy 1Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan, 121 1066CX Amsterdam, The Netherlands 2Department of Pathology, 3Nuclear Medicine Division, Department of Diagnostic Imaging and Radiotherapy and 4Scientific Directorate, IRCCS Foundation - Istituto Nazionale dei Tumori, Via G. Venezian, 1 20133 Milan, Italy (Correspondence should be addressed to A Greco; Email: [email protected]) Abstract Oncogene-induced senescence (OIS) is a growth arrest triggered by the enforced expression of cancer-promoting genes and acts as a barrier against malignant transformation in vivo. In this study, by a combination of in vitro and in vivo approaches, we investigate the role of OIS in tumours originating from the thyroid epithelium. We found that expression of different thyroid tumour-associated oncogenes in primary human thyrocytes triggers senescence, as demon- strated by the presence of OIS hallmarks: changes in cell morphology, accumulation of SA-b-Gal and senescence-associated heterochromatic foci, and upregulation of transcription of the cyclin- dependent kinase inhibitors p16INK4a and p21CIP1. Furthermore, immunohistochemical analysis of a panel of thyroid tumours characterised by different aggressiveness showed that the expression of OIS markers such as p16INK4a, p21CIP1 and IGFBP7 is upregulated at early stages, and lost during thyroid tumour progression.
  • Stress-Induced Cellular Senescence Contributes to Chronic Inflammation and Cancer Progression

    Stress-Induced Cellular Senescence Contributes to Chronic Inflammation and Cancer Progression

    Current knowledge of molecular and cellular biology of cellular senescence・ S. Kobashigawa et al. Review Thermal Med, 35 (4): 41-58, 2019. Stress-induced Cellular Senescence Contributes to Chronic Inflammation and Cancer Progression SHINKO KOBASHIGAWA1,2, YOSHIHIKO M. SAKAGUCHI1, SHINICHIRO MASUNAGA2, EIICHIRO MORI1* 1Department of Future Basic Medicine, Nara Medical University, Kashihara, Nara, 634-8521, Japan 2Kyoto University, Institute of Integrated Radiation and Nuclear Science, Kumatori, Osaka, 590-0494, Japan Abstract: Cellular senescence has long been considered to act as a tumor suppressor or tumor suppression mechanism and described as a phenomenon of irreversible cell cycle arrest. Cellular senescence, however, is now considered to have physiological functions other than tumor suppression; it has been found to be involved in embryogenesis, tissue/organ aging, and wound healing. Surprisingly, cellular senescence is also demonstrated to have a tumor progressive role in certain situations. Senescent cells exhibit secretory phenotypes called senescence-associated secretory phenotype (SASP), which secrete a variety of SASP factors including inflammatory cytokines, chemokines, and growth factors, as well as matrix remodeling factors that promote the alteration of neighboring tissue microenvironments. Such SASP factors have been known to drive the mechanisms underlying the pleiotropic features of cellular senescence. In this review, we examine current knowledge of cellular senescence at molecular and cellular levels, with a focus on chronic inflammation and tumor progression. Key Words: senescence, senescence-associated secretory phenotype (SASP), reactive oxygen species (ROS), ionizing radiation, heat shock response (HSR) 1. Introduction Hayflick and Moorhead1) were the first to describe the limited divisions of cells and term this irreversible cell cycle arrest as cellular senescence.